About this trial
This single-center study targets adults with distinct sleep profiles, divided into three categories: natural short sleepers, characterized by a reduced nocturnal sleep duration; subjects with idiopathic hypersomnia (IH) followed at the Sleep Disorders Unit of CHU Gui de Chauliac, with excessive daytime sleepiness; and control normal sleepers, with standard sleep duration and no specific complaints.
The aim of this study is to analyze the mechanisms of slow-wave regulation during sleep according to sleep phenotype (normal, short, and long sleepers/idiopathic hypersomnia) by examining the decay of EEG spectral power in the delta band over central regions during the first night of continuous 32-hour recording.
Eligibility criteria
Qualifiers
Be aged ≥ 18 years
Be affiliated with a social security system
Be able to understand the nature, purpose, and methodology of the study and agree to cooperate during clinical and polysomnographic assessments
Be fluent in French (speaking and writing)
Disqualifiers
Pre-existing sleep disorders
Use of medication that affects sleep (such as sedatives, antidepressants, and insomnia medication);
Use of substances that disrupt sleep or reduce fatigue
Serious psychiatric disorders
Trial design
Treatments tested in this trial
- Actigraphy
- Polysomnographie (PSG 128)
- TILE test
- PVT
- Blood sample
- Freestyle Libre® senso
- Questionnaires
- Home EEG monitoring
- Bioelectrical impedance analysis